Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
SynapDx
SynapDx

SynapDx

Series B

SynapDX: Pioneering early autism detection through blood-based diagnostic tests.

HQ
Lexington, MA, US
Founded
2010
Overview
Compare
Fundraising
Employees

SynapDx is dedicated to pioneering early autism detection through innovative blood-based diagnostic tests. The company's core mission is to provide early and accurate diagnostic solutions to improve outcomes for individuals with autism. SynapDx focuses on developing laboratory services that can detect autism at an early stage, aiming to transform the diagnostic landscape and support timely interventions.

SynapDx has made significant strides in the field of autism diagnostics, leveraging advanced technology to create reliable and non-invasive testing methods. Their work has the potential to revolutionize early autism detection, offering hope for better management and support for affected individuals and their families.

SynapDx - Similar Companies

Synaps Dx logo

Synaps Dx

synapsdx.com

Synaptek logo

Synaptek

MultiplexDX logo

MultiplexDX

multiplexdx.com

First Light Diagnostics logo

First Light Diagnostics

firstlightbio.com

LynxDx logo

LynxDx

lynxdx.com

TAI Diagnostics logo

TAI Diagnostics

Molecular Detection logo

Molecular Detection

Babson Diagnostics logo

Babson Diagnostics

babsondx.com

AxonDx logo

AxonDx

axondx.com

KDx Diagnostics logo

KDx Diagnostics

kdxdiagnostics.com

DxTerity Diagnostics logo

DxTerity Diagnostics

dxterity.com

Ascendant Dx logo

Ascendant Dx

ascendantdx.com

Selux Diagnostics logo

Selux Diagnostics

seluxdx.com

Nanopore Diagnostics logo

Nanopore Diagnostics

nanoporedx.com

Burst Diagnostics logo

Burst Diagnostics

burst-dx.com

SynapDx - Quick Facts

Who are SynapDx's competitors?

Companies similar to SynapDx include Synaps Dx, Synaptek, MultiplexDX and First Light Diagnostics.

When was SynapDx founded?

SynapDx was founded in 2010.

Where is SynapDx's headquarters located?

SynapDx's headquarters is located in Lexington, MA, US.

When was SynapDx's last funding round?

SynapDx's most recent funding round was for $15.4M (USD) in July 2013.

How much has SynapDx raised to-date?

As of Jul 22, 2013, SynapDx has raised a total of $32.4M (USD).

How many employees does SynapDx have?

SynapDx has 11 employees as of Feb 5, 2024.

SynapDx - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Diagnostic Tests
Tags
  • Data
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 6499Other financial service activities, except insurance and pension funding activities, n.e.c.
Show 7 more industry codes
NAICS
  • 523100Securities and Commodity Contracts Intermediation and Brokerage
  • 523150Investment Banking and Securities Intermediation
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
SIC
  • 6210Security Brokers, Dealers, And Flotation Companies
  • 6211Security Brokers, Dealers, And Flotation Companies
  • 6200Security And Commodity Brokers, Dealers, Exchanges, And Services